Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990–2010
The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalenc...
Saved in:
Published in | Optometry and vision science Vol. 93; no. 3; pp. 227 - 234 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Academy of Optometry
01.03.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 1040-5488 1538-9235 |
DOI | 10.1097/OPX.0000000000000796 |
Cover
Loading…
Abstract | The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally.
The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]4.7–8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI87.88–125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990–2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI0.1–0.2%) in 1990 to 0.1% (95% CI0.1–0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI1.6–2.4%) in 1990 to 1.5% (95% CI1.3–1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI15.2–25.9%) of all blindness and 52.9% (95% CI47.2–57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI62–72%).
We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons. |
---|---|
AbstractList | The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally. : The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]: 4.7-8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI: 87.88-125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990-2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI: 0.1-0.2%) in 1990 to 0.1% (95% CI: 0.1-0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI: 1.6-2.4%) in 1990 to 1.5% (95% CI: 1.3-1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI: 15.2-25.9%) of all blindness and 52.9% (95% CI: 47.2-57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI: 62-72%). : We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons. The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity <6/18, ≥3/60) or blindness (presenting visual acuity <3/60) due to uncorrected refractive error (URE), to estimate trends in prevalence from 1990 to 2010, and to analyze regional differences. The review focuses on uncorrected refractive error which is now the most common cause of avoidable visual impairment globally. The systematic review of 14,908 relevant manuscripts from 1990 to 2010 using Medline, Embase, and WHOLIS yielded 243 high-quality, population-based cross-sectional studies which informed a meta-analysis of trends by region. The results showed that in 2010, 6.8 million (95% confidence interval [CI]4.7–8.8 million) people were blind (7.9% increase from 1990) and 101.2 million (95% CI87.88–125.5 million) vision impaired due to URE (15% increase since 1990), while the global population increased by 30% (1990–2010). The all-age age-standardized prevalence of URE blindness decreased 33% from 0.2% (95% CI0.1–0.2%) in 1990 to 0.1% (95% CI0.1–0.1%) in 2010, whereas the prevalence of URE MSVI decreased 25% from 2.1% (95% CI1.6–2.4%) in 1990 to 1.5% (95% CI1.3–1.9%) in 2010. In 2010, URE contributed 20.9% (95% CI15.2–25.9%) of all blindness and 52.9% (95% CI47.2–57.3%) of all MSVI worldwide. The contribution of URE to all MSVI ranged from 44.2 to 48.1% in all regions except in South Asia which was at 65.4% (95% CI62–72%). We conclude that in 2010, uncorrected refractive error continues as the leading cause of vision impairment and the second leading cause of blindness worldwide, affecting a total of 108 million people or 1 in 90 persons. |
Author | Keeffe, Jill Limburg, Hans Resnikoff, Serge Taylor, Hugh R. Jonas, Jost B. Pesudovs, Konrad White, Richard A. Wong, Tien Y. Bourne, Rupert R. Price, Holly Leasher, Janet Naidoo, Kovin S. Flaxman, Seth R. |
AuthorAffiliation | OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public |
AuthorAffiliation_xml | – name: OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway (RAW); Singapore Eye Research Institute, Singapore (TYW); and Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia (HRT) |
Author_xml | – sequence: 1 givenname: Kovin surname: Naidoo middlename: S. fullname: Naidoo, Kovin S. organization: OD, PhD †OD, MPH ‡FRCOphth, MD §BA ∥MD PhD ††MD, PhD ‡‡BSc, PhD §§AC, MD African Vision Research Institute, University of KwaZulu-Natal, South Africa (KSN); Brien Holden Vision Institute, Sydney, Australia (KSN, SR); School of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia (KSN, SR); Nova Southeastern University, Ft. Lauderdale, Florida (JL); Vision & Eye Research Unit, Anglia Ruskin University, Cambridge, United Kingdom (RRB, HP); School of Computer Science & Heinz College, Carnegie Mellon University, Pittsburgh, Pennsylvania (SRF); Department of Ophthalmology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany (JBJ); L. V. Prasad Eye Institute, Hyderabad, India (JK); Health Information Services, Grootebroek, Netherlands (HL); NHMRC Centre for Clinical Eye Research, Flinders University, Adelaide, South Australia, Australia (KP); Department of Genes and Environment, Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway (RAW); Singapore Eye Research Institute, Singapore (TYW); and Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia (HRT) – sequence: 2 givenname: Janet surname: Leasher fullname: Leasher, Janet – sequence: 3 givenname: Rupert surname: Bourne middlename: R. fullname: Bourne, Rupert R. – sequence: 4 givenname: Seth surname: Flaxman middlename: R. fullname: Flaxman, Seth R. – sequence: 5 givenname: Jost surname: Jonas middlename: B. fullname: Jonas, Jost B. – sequence: 6 givenname: Jill surname: Keeffe fullname: Keeffe, Jill – sequence: 7 givenname: Hans surname: Limburg fullname: Limburg, Hans – sequence: 8 givenname: Konrad surname: Pesudovs fullname: Pesudovs, Konrad – sequence: 9 givenname: Holly surname: Price fullname: Price, Holly – sequence: 10 givenname: Richard surname: White middlename: A. fullname: White, Richard A. – sequence: 11 givenname: Tien surname: Wong middlename: Y. fullname: Wong, Tien Y. – sequence: 12 givenname: Hugh surname: Taylor middlename: R. fullname: Taylor, Hugh R. – sequence: 13 givenname: Serge surname: Resnikoff fullname: Resnikoff, Serge |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26905537$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkMtOFzEUhxuDkYu-gTFdunCwt-nFnSIgCQnGiLprOtMzodpp_7YdiTvewTf0SRwEEsPKszmXfL-z-HbRVsoJEHpKyT4lRr08e_9ln_xbysgHaIf2XHeG8X5rnYkgXS-03ka7tX4lhCrey0dom0lD-p6rHfT5OObBRfwp1JATPpk3LpQZUsMuefwmhuQT1IrfLoBbxudpzKXA2MDjDzAVN7bwA_BhKbm8wNQY8vvqFyOUPEYPJxcrPLnte-j86PDjwbvu9Oz45OD1aTdyoXmnBjGAdMR475znegTqnaCe9b1iXElPpdNCE6MnxgY-MeWMoHpwHCQh3PE99Pzm76bk7wvUZudQR4jRJchLtVRJTaXShqzos1t0GWbwdlPC7MpPeydjBV7dAGPJtRaY7Biaa6uXVlyIlhJ7bd6u5u1982tY3Avf_f-_2GWODUr9FpdLKPYCXGwXf3HJmehWpZLwdeuuT5z_AYV8k4c |
CitedBy_id | crossref_primary_10_1136_bjophthalmol_2019_315103 crossref_primary_10_1038_s41746_019_0154_5 crossref_primary_10_1145_3550283 crossref_primary_10_1177_11206721231184544 crossref_primary_10_1016_j_ajo_2018_09_020 crossref_primary_10_1080_08164622_2023_2202305 crossref_primary_10_1097_ICL_0000000000000907 crossref_primary_10_1371_journal_pone_0215329 crossref_primary_10_1080_08164622_2022_2107891 crossref_primary_10_1167_tvst_14_1_8 crossref_primary_10_4103_joco_joco_337_21 crossref_primary_10_1097_OPX_0000000000001308 crossref_primary_10_4103_joco_joco_56_21 crossref_primary_10_1038_s41433_020_1009_7 crossref_primary_10_1097_OPX_0000000000001143 crossref_primary_10_1097_OPX_0000000000001661 crossref_primary_10_1016_j_measurement_2018_02_021 crossref_primary_10_2139_ssrn_3901777 crossref_primary_10_4103_djo_djo_70_21 crossref_primary_10_4103_pajo_pajo_5_24 crossref_primary_10_4103_ijo_IJO_982_17 crossref_primary_10_3928_1081597X_20170310_01 crossref_primary_10_1038_s41433_019_0469_0 crossref_primary_10_1016_j_ajo_2024_11_012 crossref_primary_10_1016_j_joco_2017_05_006 crossref_primary_10_1186_s12886_023_02994_2 crossref_primary_10_1016_j_joco_2017_05_004 crossref_primary_10_1186_s12982_025_00481_1 crossref_primary_10_1080_02713683_2018_1485953 crossref_primary_10_4103_ijo_IJO_3503_20 crossref_primary_10_3389_fpsyg_2022_954328 crossref_primary_10_7759_cureus_37834 crossref_primary_10_1111_cxo_12646 crossref_primary_10_1111_ceo_12954 crossref_primary_10_1371_journal_pone_0211186 crossref_primary_10_1136_bjophthalmol_2018_312573 crossref_primary_10_1080_08820538_2018_1539182 crossref_primary_10_1136_bjo_2023_323468 crossref_primary_10_1007_s40123_023_00842_6 crossref_primary_10_1097_ICU_0000000000000376 crossref_primary_10_1007_s10792_024_03178_7 crossref_primary_10_1016_j_jfo_2024_104381 crossref_primary_10_1097_MD_0000000000027758 crossref_primary_10_1080_09286586_2017_1376338 crossref_primary_10_1117_1_OE_61_12_121809 crossref_primary_10_1371_journal_pone_0271313 crossref_primary_10_1186_s12886_021_01996_2 crossref_primary_10_24875_RMO_M21000201 crossref_primary_10_1186_s12889_024_20387_y crossref_primary_10_1111_opo_13172 crossref_primary_10_2144_fsoa_2022_0075 crossref_primary_10_18502_jovr_v17i2_10794 crossref_primary_10_7759_cureus_29925 crossref_primary_10_1016_j_joco_2017_08_009 crossref_primary_10_1016_j_puhe_2017_09_004 crossref_primary_10_1111_cxo_12650 crossref_primary_10_4103_ijo_IJO_2098_21 crossref_primary_10_61919_jhrr_v4i3_1530 crossref_primary_10_4236_ojoph_2024_143030 crossref_primary_10_1097_ICU_0000000000000548 crossref_primary_10_1097_OPX_0000000000002000 crossref_primary_10_1371_journal_pone_0313220 crossref_primary_10_1007_s40123_021_00360_3 crossref_primary_10_1097_APO_0000000000000488 crossref_primary_10_18502_jovr_v17i1_10173 crossref_primary_10_1177_0145482X211016570 crossref_primary_10_1371_journal_pone_0162229 crossref_primary_10_4103_ijo_IJO_2724_20 crossref_primary_10_1186_s12886_021_02134_8 crossref_primary_10_1016_j_optom_2022_07_003 crossref_primary_10_3389_fmed_2023_1141438 crossref_primary_10_1016_S2468_2667_20_30254_1 crossref_primary_10_4102_aveh_v75i1_355 crossref_primary_10_1186_s12889_021_11648_1 crossref_primary_10_1146_annurev_vision_091718_015027 crossref_primary_10_1016_j_joco_2017_04_003 crossref_primary_10_3389_fmed_2021_759767 crossref_primary_10_1186_s12886_017_0561_9 crossref_primary_10_1016_j_survophthal_2023_07_001 crossref_primary_10_21516_2072_0076_2022_15_2_supplement_98_103 crossref_primary_10_1080_09286586_2021_1919311 crossref_primary_10_1016_j_joco_2018_12_001 crossref_primary_10_1186_s12886_021_02145_5 crossref_primary_10_1186_s13584_019_0339_z crossref_primary_10_1186_s13584_025_00667_7 crossref_primary_10_1186_s12909_019_1738_0 crossref_primary_10_1136_bjo_2022_322123 crossref_primary_10_1016_S0140_6736_18_33209_4 crossref_primary_10_3390_healthcare10020405 crossref_primary_10_1371_journal_pone_0191199 crossref_primary_10_1016_j_aopr_2024_06_005 crossref_primary_10_4103_JOCO_JOCO_224_20 crossref_primary_10_4103_JOCO_JOCO_100_20 crossref_primary_10_1016_j_clae_2021_101518 crossref_primary_10_3389_fmed_2021_753257 crossref_primary_10_1136_bjophthalmol_2021_318828 crossref_primary_10_1186_s12886_024_03372_2 crossref_primary_10_1007_s10384_022_00900_9 crossref_primary_10_1001_jamaophthalmol_2018_4229 crossref_primary_10_1016_j_jaapos_2021_07_013 crossref_primary_10_1371_journal_pone_0192055 crossref_primary_10_1016_j_ophtha_2022_05_020 crossref_primary_10_1016_j_joco_2017_02_007 crossref_primary_10_1007_s00038_017_1000_7 crossref_primary_10_1016_j_joco_2018_08_001 crossref_primary_10_1016_j_puhe_2020_10_028 crossref_primary_10_1371_journal_pone_0240933 crossref_primary_10_1097_OPX_0000000000002054 crossref_primary_10_1016_j_cub_2024_02_052 crossref_primary_10_4102_aveh_v79i1_534 crossref_primary_10_1371_journal_pone_0268800 crossref_primary_10_1167_iovs_61_10_11 crossref_primary_10_3389_fnut_2022_1038963 crossref_primary_10_4102_aveh_v77i1_392 crossref_primary_10_1111_cxo_13025 crossref_primary_10_3389_fneur_2025_1465444 crossref_primary_10_1016_j_yaoo_2021_04_020 crossref_primary_10_18231_j_ijceo_2021_085 crossref_primary_10_36320_ajb_v14_i2_11349 crossref_primary_10_1080_08164622_2021_1993057 crossref_primary_10_1097_ICL_0000000000000360 crossref_primary_10_1097_OPX_0000000000001998 crossref_primary_10_4103_1319_4534_301297 crossref_primary_10_1016_j_aopr_2021_100010 crossref_primary_10_1136_bjophthalmol_2018_312428 crossref_primary_10_1001_jamaophthalmol_2020_1677 crossref_primary_10_1007_s10384_021_00828_6 crossref_primary_10_1097_OPX_0000000000001356 crossref_primary_10_4103_ijo_IJO_1333_17 crossref_primary_10_4103_sjhs_sjhs_81_22 crossref_primary_10_4103_ijo_IJO_869_16 crossref_primary_10_4103_sjopt_sjopt_46_21 crossref_primary_10_2147_OPTH_S440578 |
Cites_doi | 10.1167/iovs.03-0283 10.1016/j.ophtha.2013.05.025 10.1016/S0002-9394(99)00453-5 10.1016/S0140-6736(12)61689-4 10.2471/BLT.07.041210 10.1016/S0002-9394(99)00454-7 10.1016/S0002-9394(99)00452-3 10.1076/opep.8.1.39.1540 10.4103/0974-9233.80695 10.4103/0301-4738.100543 10.1016/S2214-109X(13)70113-X 10.2471/BLT.08.055673 |
ContentType | Journal Article |
Copyright | 2016 American Academy of Optometry |
Copyright_xml | – notice: 2016 American Academy of Optometry |
CorporateAuthor | Vision Loss Expert Group of the Global Burden of Disease Study |
CorporateAuthor_xml | – name: Vision Loss Expert Group of the Global Burden of Disease Study |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1097/OPX.0000000000000796 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-9235 |
EndPage | 234 |
ExternalDocumentID | 26905537 10_1097_OPX_0000000000000796 00006324-201603000-00003 |
Genre | Meta-Analysis Research Support, Non-U.S. Gov't Systematic Review Journal Article |
GroupedDBID | --- -~X .GJ .Z2 0R~ 123 4Q1 4Q2 4Q3 53G 5VS 71W AAAAV AAHPQ AAIQE AAMTA AARTV AASCR AAWTL ABASU ABBUW ABDIG ABDPE ABJNI ABPXF ABVCZ ABXRP ABXVJ ABZAD ABZZY ACDDN ACEWG ACGFO ACGFS ACILI ACNCT ACWDW ACWRI ACXJB ACXNZ ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AHQNM AHRYX AHVBC AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BQLVK BS7 C45 CS3 DIK DIWNM DU5 DUNZO E.X EBS EEVPB EJD EX3 F5P FCALG FL- GNXGY GQDEL H0~ HLJTE HZ~ IKREB IN~ JF9 JG8 JK3 JK8 K8S KD2 L-C N~M O9- OAG OAH OCUKA ODA OK1 OLG OPUJH ORVUJ OUVQU OVD OVDNE OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P P6G R58 RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M WH7 WOQ WOW X3V X3W XOL XXN XYM YFH ZB8 ZFV ZXP ZZMQN AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3483-7b4be6a09ddaad38ce1da41d25572376d16a848098f22b3f27a9418ba3e6003a3 |
ISSN | 1040-5488 |
IngestDate | Fri Jul 11 15:06:58 EDT 2025 Sat Jun 28 01:34:47 EDT 2025 Tue Jul 01 03:22:56 EDT 2025 Thu Apr 24 22:58:10 EDT 2025 Fri May 16 04:02:16 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3483-7b4be6a09ddaad38ce1da41d25572376d16a848098f22b3f27a9418ba3e6003a3 |
Notes | SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Review-1 ObjectType-Article-3 ObjectType-Undefined-4 |
PMID | 26905537 |
PQID | 1768167890 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_1768167890 pubmed_primary_26905537 crossref_citationtrail_10_1097_OPX_0000000000000796 crossref_primary_10_1097_OPX_0000000000000796 wolterskluwer_health_00006324-201603000-00003 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-March 2016-03-00 2016-Mar 20160301 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: 2016-March |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Optometry and vision science |
PublicationTitleAlternate | Optom Vis Sci |
PublicationYear | 2016 |
Publisher | American Academy of Optometry |
Publisher_xml | – name: American Academy of Optometry |
References | Maul (R9-3-20210202) 2000; 129 Murthy (R12-3-20210202) 2002; 43 Pokharel (R7-3-20210202) 2000; 129 Naidoo (R3-3-20210202) 2012; 60 Mganga (R19-3-20210202) 2011; 18 Abou-Gareeb (R18-3-20210202) 2001; 8 Bourne (R2-3-20210202) 2013; 1 Stevens (R13-3-20210202) 2013; 120 Zhao (R8-3-20210202) 2000; 129 Dandona (R11-3-20210202) 2002; 43 Naidoo (R10-3-20210202) 2003; 44 Dandona (R17-3-20210202) 2006; 4 Resnikoff (R1-3-20210202) 2008; 86 Smith (R4-3-20210202) 2009; 87 Murray (R15-3-20210202) 2012; 380 |
References_xml | – volume: 44 start-page: 3764 year: 2003 ident: R10-3-20210202 article-title: Refractive error and visual impairment in African children in South Africa. publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.03-0283 – volume: 4 start-page: 6 year: 2006 ident: R17-3-20210202 article-title: What is the global burden of visual impairment BMC M publication-title: ed – volume: 120 start-page: 2377 year: 2013 ident: R13-3-20210202 article-title: Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. publication-title: Ophthalmology doi: 10.1016/j.ophtha.2013.05.025 – volume: 129 start-page: 436 year: 2000 ident: R7-3-20210202 article-title: Refractive Error Study in Children: results from Mechi Zone, Nepal. publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(99)00453-5 – volume: 380 start-page: 2197 year: 2012 ident: R15-3-20210202 article-title: Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. publication-title: Lancet doi: 10.1016/S0140-6736(12)61689-4 – volume: 86 start-page: 63 year: 2008 ident: R1-3-20210202 article-title: Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. publication-title: Bull World Health Organ doi: 10.2471/BLT.07.041210 – volume: 129 start-page: 445 year: 2000 ident: R9-3-20210202 article-title: Refractive Error Study in Children: results from La Florida, Chile. publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(99)00454-7 – volume: 43 start-page: 615 year: 2002 ident: R11-3-20210202 article-title: Refractive error in children in a rural population in India. publication-title: Invest Ophthalmol Vis Sci – volume: 129 start-page: 427 year: 2000 ident: R8-3-20210202 article-title: Refractive Error Study in Children: results from Shunyi District, China. publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(99)00452-3 – volume: 43 start-page: 623 year: 2002 ident: R12-3-20210202 article-title: Refractive error in children in an urban population in New Delhi. publication-title: Invest Ophthalmol Vis Sci – volume: 8 start-page: 39 year: 2001 ident: R18-3-20210202 article-title: Gender and blindness: a meta-analysis of population-based prevalence surveys. publication-title: Ophthalmic Epidemiol doi: 10.1076/opep.8.1.39.1540 – volume: 18 start-page: 98 year: 2011 ident: R19-3-20210202 article-title: Overcoming gender inequity in prevention of blindness and visual impairment in Africa. publication-title: Middle East Afr J Ophthalmol doi: 10.4103/0974-9233.80695 – volume: 60 start-page: 432 year: 2012 ident: R3-3-20210202 article-title: Uncorrected refractive errors. publication-title: Indian J Ophthalmol doi: 10.4103/0301-4738.100543 – volume: 1 start-page: e339 year: 2013 ident: R2-3-20210202 article-title: Causes of vision loss worldwide, 1990-2010: a systematic analysis. publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(13)70113-X – volume: 87 start-page: 431 year: 2009 ident: R4-3-20210202 article-title: Potential lost productivity resulting from the global burden of uncorrected refractive error. publication-title: Bull World Health Organ doi: 10.2471/BLT.08.055673 |
SSID | ssj0017356 |
Score | 2.5067387 |
SecondaryResourceType | review_article |
Snippet | The purpose of this systematic review was to estimate worldwide the number of people with moderate and severe visual impairment (MSVI; presenting visual acuity... |
SourceID | proquest pubmed crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 227 |
SubjectTerms | Adult Blindness - epidemiology Blindness - etiology Cross-Sectional Studies Female Global Health - statistics & numerical data Humans Male Middle Aged Persons with Visual Disabilities - statistics & numerical data Prevalence Refractive Errors - complications Refractive Errors - epidemiology Refractive Errors - therapy Vision, Low - epidemiology Vision, Low - etiology Visual Acuity |
Title | Global Vision Impairment and Blindness Due to Uncorrected Refractive Error, 1990–2010 |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00006324-201603000-00003 https://www.ncbi.nlm.nih.gov/pubmed/26905537 https://www.proquest.com/docview/1768167890 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAiEJu4rDGQk3ka2OHac5JHdNDbGEFpR3yI7dsW0ramyFCR-Pcd27GQXxKUPVZW0juTz9eSck_N9B6G3FHJkwmMVaVnkEaMijQqt04jqWHCVyaJKDVH48BPfG7P9STrpW4Isu6SV69XPG3kl_2NVOAZ2NSzZf7BsWBQOwGewL7yDheH9r2zsBPvXvlp-uBH6FSdNaBrfhABSWUe2vbDzMcZGstI4OG0oiVNLj_quwRM2LmUncMuIzGPrYcB6NG_rc902TqbJMdHXuttmKCSLE1XbkuuBqU_01dSPWvjB6vti1lOtN0Ml9ctirpu271rcPROhJqvbb92JripBeN-Wta4HnjRxWiTe1bphiB2k6NBvOoGAa_7c6QQffZ44nUn_ytwU3IGJ5-fWxgkk-2nqZGSu6Gj7U7fRnQRSCjPtYvvDQXjilNGUe2plkW3cdEkjHN0tcjmKuZaa3EcPftSm2-Hi1JIdBiHL8UO03OUa-L0DziN0S88eo7uHXTfFEzR2-MEOP7jHDwZb44AfDPjBbY0H-ME9frDFzzsc0PMUjXd3jrf2om7MRlRRltMok0xqLuJCKSEUzStNlGBEQbKZmZ4pRbjIWR4X-TRJJJ0mmSgYyaWgGqJlKugztDSrZ3oF4SlNlWIKUtY4ZzTOJYRCFYS4SnKhVcpHiPptK6tOg96MQjkrfS8E7Ht5dd9HKAq_mjsNlj98_423SAnO0jwBA4zXi4uSQHJNuOF-j9BzZ6qwojctXO2S7UpHSLZXMbMNzFZyuDU6RYaYvvjtSi_Rvf6vsYqW2mahX0EI28rXFnu_ADL_kD8 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+Vision+Impairment+and+Blindness+Due+to+Uncorrected+Refractive+Error%2C+1990-2010&rft.jtitle=Optometry+and+vision+science&rft.au=Naidoo%2C+Kovin+S&rft.au=Leasher%2C+Janet&rft.au=Bourne%2C+Rupert+R&rft.au=Flaxman%2C+Seth+R&rft.date=2016-03-01&rft.eissn=1538-9235&rft.volume=93&rft.issue=3&rft.spage=227&rft_id=info:doi/10.1097%2FOPX.0000000000000796&rft_id=info%3Apmid%2F26905537&rft.externalDocID=26905537 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-5488&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-5488&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-5488&client=summon |